Related Experiment Video
Updated: May 12, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
Published on: February 5, 2015
Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis
Daniela F Angelini1, Barbara Serafini, Eleonora Piras
1Neuroimmunology Unit, Fondazione Santa Lucia-I.R.C.C.S., Rome, Italy.
Abstract:
It has long been known that multiple sclerosis (MS) is associated with an increased Epstein-Barr virus (EBV) seroprevalence and high immune reactivity to EBV and that infectious mononucleosis increases MS risk. This evidence led to postulate that EBV infection plays a role in MS etiopathogenesis, although the mechanisms are debated. This study was designed to assess the prevalence and magnitude of CD8+ T-cell responses to EBV latent (EBNA-3A, LMP-2A) and lytic (BZLF-1, BMLF-1) antigens in relapsing-remitting MS patients (n = 113) and healthy donors (HD) (n = 43) and to investigate whether the EBV-specific CD8+ T cell response correlates with disease activity, as defined by clinical evaluation and gadolinium-enhanced magnetic resonance imaging. Using HLA class I pentamers, lytic antigen-specific CD8+ T cell responses were detected in fewer untreated inactive MS patients than in active MS patients and HD while the frequency of CD8+ T cells specific for EBV lytic and latent antigens was higher in active and inactive MS patients, respectively. In contrast, the CD8+ T cell response to cytomegalovirus did not differ between HD and MS patients, irrespective of the disease phase. Marked differences in the prevalence of EBV-specific CD8+ T cell responses were observed in patients treated with interferon-β and natalizumab, two licensed drugs for relapsing-remitting MS. Longitudinal studies revealed expansion of CD8+ T cells specific for EBV lytic antigens during active disease in untreated MS patients but not in relapse-free, natalizumab-treated patients. Analysis of post-mortem MS brain samples showed expression of the EBV lytic protein BZLF-1 and interactions between cytotoxic CD8+ T cells and EBV lytically infected plasma cells in inflammatory white matter lesions and meninges. We therefore propose that inability to control EBV infection during inactive MS could set the stage for intracerebral viral reactivation and disease relapse.
Insights
Epstein-Barr virus (EBV) reactivation may trigger multiple sclerosis (MS) relapses. Controlling EBV infection is crucial for managing MS disease activity and preventing relapses.
Area of Science:
- Immunology
- Neuroscience
- Virology
Background:
- Multiple sclerosis (MS) is linked to increased Epstein-Barr virus (EBV) seroprevalence and immune reactivity.
- Infectious mononucleosis, caused by EBV, is a known risk factor for MS.
- The precise role and mechanisms of EBV in MS pathogenesis remain debated.
Purpose of the Study:
- To assess CD8+ T-cell responses to EBV latent and lytic antigens in relapsing-remitting MS patients and healthy donors.
- To investigate the correlation between EBV-specific CD8+ T-cell responses and MS disease activity.
- To analyze EBV-specific T-cell responses in MS patients treated with interferon-β and natalizumab.
Main Methods:
- Quantification of CD8+ T-cell responses to EBV latent (EBNA-3A, LMP-2A) and lytic (BZLF-1, BMLF-1) antigens using HLA class I pentamers.
- Comparison of responses between MS patients (n=113) and healthy donors (n=43), stratified by disease activity and treatment.
- Analysis of cytomegalovirus-specific CD8+ T-cell responses as a control.
- Longitudinal assessment of T-cell responses during disease flares and remission.
- Examination of post-mortem MS brain tissue for EBV protein expression and immune cell interactions.
Main Results:
- CD8+ T-cell responses to EBV lytic antigens were lower in untreated inactive MS patients compared to active MS patients and healthy donors.
- Frequencies of CD8+ T cells specific for EBV lytic and latent antigens were higher in active and inactive MS patients, respectively.
- EBV-specific CD8+ T-cell responses differed significantly in patients treated with interferon-β and natalizumab.
- Expansion of EBV lytic antigen-specific CD8+ T cells occurred during active disease in untreated MS patients.
- EBV protein BZLF-1 expression and CD8+ T-cell interactions with infected plasma cells were observed in MS brain lesions.
Conclusions:
- Inability to control EBV infection during inactive MS may predispose to intracerebral viral reactivation and disease relapse.
- EBV reactivation is proposed as a potential trigger for MS relapses.
- These findings highlight the critical role of EBV control in managing MS.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Multiple Sclerosis l: Introduction
